{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,9]],"date-time":"2025-10-09T06:21:26Z","timestamp":1759990886233},"reference-count":21,"publisher":"Cambridge University Press (CUP)","issue":"3","license":[{"start":{"date-parts":[[2015,7,10]],"date-time":"2015-07-10T00:00:00Z","timestamp":1436486400000},"content-version":"unspecified","delay-in-days":0,"URL":"https:\/\/www.cambridge.org\/core\/terms"}],"content-domain":{"domain":["journals.cambridge.org"],"crossmark-restriction":true},"short-container-title":["Epidemiol. Infect."],"published-print":{"date-parts":[[2016,2]]},"abstract":"<jats:title>SUMMARY<\/jats:title><jats:p>We aimed to assess vaccination coverage (VC) in 17-year-old French young adults (YAs) participating in one mandatory Day of Defence and Citizenship (DDC). Between June 2010 and May 2011, YAs participating in 43 randomly selected mandatory sessions of the DDC programme in Poitou-Charentes (France) were asked to provide their personal vaccination record. Tetanus, diphtheria, polio, hepatitis B, <jats:italic>Haemophilus influenzae<\/jats:italic> b, pertussis, measles, mumps and rubella vaccination status were assessed at ages 2, 6, 13 and 17 years. Of 2610 participants, 2111 (81%) supplied documents for evaluation. Of these, 1838 (87%, M:F sex ratio 0\u00b796) were aged 17 years (9% of the global population of this age in the area). The assessment of the 17-year-olds demonstrated the following rates of complete vaccination: diphtheria-tetanus-polio 83%; measles, mumps and rubella 83%; pertussis 69%; <jats:italic>H. influenzae<\/jats:italic> b 61%; human papillomavirus 47%; and hepatitis B 40%. At age 6 years, only 46% had received two doses of the vaccine against measles. The YAs were not aware of their status but were in favour of vaccination. VC in YAs is insufficient, particularly for hepatitis B, pertussis and measles. Combined vaccines and the simplification of vaccination schedules should improve VC. Preventive messages should focus on YAs.<\/jats:p>","DOI":"10.1017\/s0950268815001533","type":"journal-article","created":{"date-parts":[[2015,7,10]],"date-time":"2015-07-10T04:57:11Z","timestamp":1436504231000},"page":"612-617","update-policy":"http:\/\/dx.doi.org\/10.1017\/policypage","source":"Crossref","is-referenced-by-count":3,"title":["Vaccination coverage in French 17-year-old young adults: an assessment of mandatory and recommended vaccination statuses"],"prefix":"10.1017","volume":"144","author":[{"given":"F.","family":"ROBLOT","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S.","family":"ROBIN","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"C.","family":"CHUBILLEAU","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J.","family":"GIRAUD","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"B.","family":"BOUFFARD","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"P.","family":"INGRAND","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"56","published-online":{"date-parts":[[2015,7,10]]},"reference":[{"key":"S0950268815001533_ref1","doi-asserted-by":"publisher","DOI":"10.3201\/eid1903.121360"},{"key":"S0950268815001533_ref15","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2012.11.090"},{"key":"S0950268815001533_ref11","article-title":"Why are young adults affected? Estimating measles vaccination coverage in 20\u201334 year old Germans in order to verify progress towards measles elimination","volume":"7","author":"Schuster","year":"2015","journal-title":"PLoS Currents"},{"key":"S0950268815001533_ref8","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2334-13-181"},{"key":"S0950268815001533_ref12","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2013.04.004"},{"key":"S0950268815001533_ref9","first-page":"95","article-title":"Vaccination coverage among adults, excluding influenza vaccination \u2013 United States, 2013","volume":"64","author":"Williams","year":"2015","journal-title":"Morbidity and Mortality Weekly Report"},{"key":"S0950268815001533_ref10","doi-asserted-by":"publisher","DOI":"10.1111\/j.1469-0691.2012.03982.x"},{"key":"S0950268815001533_ref13","doi-asserted-by":"publisher","DOI":"10.1016\/j.medmal.2013.07.001"},{"key":"S0950268815001533_ref5","doi-asserted-by":"publisher","DOI":"10.1016\/j.arcped.2012.12.019"},{"key":"S0950268815001533_ref2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jadohealth.2013.07.022"},{"key":"S0950268815001533_ref3","volume-title":"Sampling Techniques","author":"Cochran","year":"1977"},{"key":"S0950268815001533_ref4","doi-asserted-by":"crossref","first-page":"329","DOI":"10.3917\/spub.124.0329","article-title":"Adult vaccination coverage: surveys in four populations. Isere (France), 2002\u20132003","volume":"24","author":"Goirand","year":"2012","journal-title":"Sant\u00e9 Publique"},{"key":"S0950268815001533_ref7","doi-asserted-by":"publisher","DOI":"10.2105\/AJPH.2009.176628"},{"key":"S0950268815001533_ref20","unstructured":"Guthmann JP , Fonteneau L , L\u00e9vy-Bruhl D . Assessment of vaccination coverage in France: current sources and data. Saint-Maurice: French Institute for Public Health Surveillance, 2012."},{"key":"S0950268815001533_ref21","doi-asserted-by":"publisher","DOI":"10.1016\/j.arcped.2006.12.006"},{"key":"S0950268815001533_ref17","doi-asserted-by":"publisher","DOI":"10.1016\/j.medmal.2013.03.003"},{"key":"S0950268815001533_ref18","doi-asserted-by":"publisher","DOI":"10.1007\/s10900-015-9995-2"},{"key":"S0950268815001533_ref14","first-page":"1382","article-title":"Progress toward implementation of human papillomavirus vaccination \u2013 The Americas, 2006\u20132010","volume":"60","year":"2011","journal-title":"Morbidity and Mortality Weekly Report"},{"key":"S0950268815001533_ref19","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2011.02.064"},{"key":"S0950268815001533_ref6","first-page":"482","article-title":"Global routine vaccination coverage, 2012","volume":"88","year":"2013","journal-title":"Weekly Epidemiological Record"},{"key":"S0950268815001533_ref16","doi-asserted-by":"crossref","DOI":"10.2807\/ese.15.47.19730-en","article-title":"The current state of introduction of human papillomavirus into natal immunization schedules in Europe: first results of the VENICE2 2010 survey","volume":"15","author":"Dorleans","year":"2010","journal-title":"Eurosurveillance"}],"container-title":["Epidemiology and Infection"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cambridge.org\/core\/services\/aop-cambridge-core\/content\/view\/S0950268815001533","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,4,19]],"date-time":"2019-04-19T23:00:19Z","timestamp":1555714819000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cambridge.org\/core\/product\/identifier\/S0950268815001533\/type\/journal_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,7,10]]},"references-count":21,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2016,2]]}},"alternative-id":["S0950268815001533"],"URL":"https:\/\/doi.org\/10.1017\/s0950268815001533","relation":{},"ISSN":["0950-2688","1469-4409"],"issn-type":[{"value":"0950-2688","type":"print"},{"value":"1469-4409","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,7,10]]},"assertion":[{"value":"Copyright \u00a9 Cambridge University Press 2015\u00a0","name":"license","label":"License","group":{"name":"copyright_and_licensing","label":"Copyright and Licensing"}}]}}